TECHNOLOGY
Can Trump ever be wrong? His pick to lead FDA refused to say.
Ars TechnicaFriday, September 25, 2026 at 11:00 PM
RedScroll Brief

Heidi Overton faced questions focused on vaccines, birth control, and vapes.
RedScroll Signal
- Impact
- High
- Category
- Technology
- Market relevance
- Moderate
- Why it matters
- Technology shifts change how people work, communicate, and build — often faster than policy can follow. Heidi Overton faced questions focused on vaccines, birth control, and vapes. Secondary effects may show up in markets and supply chains linked to Trump and Can Trump.
Desk copy
RedScroll Briefing
Extractive editorial brief — not a reprint of the original
What happened
Heidi Overton faced questions focused on vaccines, birth control, and vapes.
Why it matters
Technology shifts change how people work, communicate, and build — often faster than policy can follow.
Background
Ars Technica reported on this under technology. RedScroll surfaces the signal with an extractive brief — not a reprint of the original article. Read the source for full reporting.
Timeline
Ars Technica published: Can Trump ever be wrong? His pick to lead FDA refused to say.
Story is in today’s RedScroll edition. Follow the original source for updates.
Economic impact
Secondary effects may show up in markets and supply chains linked to Trump and Can Trump.
More on
Related stories
- The Download: the Pentagon’s AI-powered lie detector and young organ limits
MIT Technology ReviewTECHNOLOGY
- The Download: a bid to scrap the virtual wall and AI hits Climate Week
MIT Technology ReviewTECHNOLOGY
- The Download: India’s smart glasses menace and AI’s trillion-dollar gamble
MIT Technology ReviewTECHNOLOGY
- Court rules Pentagon can blacklist Anthropic for refusing to enable Claude features
Ars TechnicaTECHNOLOGY
- Tesla workers balk at training Optimus humanoid robots as replacements
Ars TechnicaTECHNOLOGY
- Review: The iPhone 18 Pro is Apple's coolest smartphone (but only literally)
Ars TechnicaTECHNOLOGY
Source
Ars Technica
Original reporting by Ars Technica. RedScroll provides an extractive briefing only.